Bigger not Always Better: Larial Proteomics Endures Homelessness, Proteomics Downturn, and Recession | GenomeWeb

By Tony Fong

In a world in which instinct instructs that to become better a company must get bigger, Larial Proteomics has taken the opposite approach.

The strategy, adopted by founder and CEO Jeffrey Charuk, has so far enabled Larial to remain afloat even as other proteomic-service firms closed down or abandoned the discipline.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.